Comparing of Efficacy and Safety Between Sintilimab Plus IBI305 and PD-1 Inhibitor Plus TKIs in Combination of TACE for uHCC. [PDF]
Ya H +8 more
europepmc +1 more source
Advances and Emerging Techniques in Transarterial Chemoembolization for Hepatocellular Carcinoma. [PDF]
Gazda HL +4 more
europepmc +1 more source
Cone-beam CT-derived parenchymal blood volume imaging in transarterial chemoembolization for hypovascular hepatic metastases: a case report. [PDF]
Wang H +10 more
europepmc +1 more source
Value of contrast-enhanced endoscopic ultrasound and elastography in the diagnosis and evaluation of portal vein thrombus. [PDF]
Li J +6 more
europepmc +1 more source
Application of Preoperative Transarterial Chemoembolization Before Hilar Liver Tumour Resection in a Dog. [PDF]
Son H, Jeon S, Kim J, Lee S.
europepmc +1 more source
Psychological crisis in patients with primary liver cancer after transarterial chemoembolization: epidemiological characteristics and associated factors. [PDF]
Zhang S, Han T.
europepmc +1 more source
TACE-HAIC Plus Targeted Therapy and Immunotherapy for HCC with Tumor Thrombus and Arteriovenous Fistula. [PDF]
Liu X, Yin L, Liu B, Hou X, Li Y, Liu R.
europepmc +1 more source
Impact of Prior Treatment History on Recurrence After Complete Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma. [PDF]
Nakabori T +11 more
europepmc +1 more source
Individualized treatment strategies for primary hepatic neuroendocrine carcinoma: Two case reports and literature review (A CARE-compliant case report). [PDF]
Hu H, Chen K, Xiao H, Lan X.
europepmc +1 more source
Sorafenib Combined with Tislelizumab and Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: A Phase II Study. [PDF]
Liang L +13 more
europepmc +1 more source

